Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2021 May 4;47(5):e336. doi: 10.1016/j.ejso.2021.03.154

P150. Development of a safe one stop and surgical pathway during the COVID-19 pandemic first peak

Rebekah Law 1, Nikki Snuggs 1, Rachel O'Connell 1, Abeera Abbas 1, Fiona MacNeill 1, Jennifer Rusby 1, Peter Barry 1, Katherine Krupa 1, William Allum 1, Gerald Gui 1, Nicola Roche 1, Marios Konstantinos Tasoulis 1
PMCID: PMC8096306

Introduction: The aim of this audit was to compare activity at our institution during the first pandemic peak with the same time period in 2019.

Methods: We compared breast one-stop clinic and surgical activity from 01/04/2020-01/07/2020 to the 2019 period. A pathway was developed for one-stop clinics whereby patients had a telephone triage to stratify their hospital appointment according to risk. A surgical pathway was developed whereby patients isolated for 14 days before surgery and had a COVID-19 swab three days before surgery.

Results: Audit approval was gained. 1027 patients were referred to the one-stop clinic, compared to 1933 the year before (47% reduction). 67 patients were diagnosed with breast cancer, 61 (91%) had no delay in diagnosis, for the 6 that did, the delay was 37.5 days (range=17-44). 333 breast cancer surgery operations were performed, compared to 412 the previous year (19% reduction). In 2020 the unplanned re-admissions were 2 (0.6%) compared to 9 (2.1%) in 2019. Unplanned returns to theatre were 4 (1.2%) and 8 (1.9%) respectively. All surgical patients were contacted 28 days after discharge and no-one was diagnosed with COVID-19. 75 patients had their surgery deferred, all of whom have now had appropriate management instigated.

Conclusions: Introduction of these clinic and surgical pathways allowed continuation of services during the pandemic. The pathways were safe, with low surgical re-admission/theatre return rates and no patient developed COVID-19 within 28 days. 91% of patients did not experience a delay in diagnosis. The delays are likely to be non-clinically significant.


Articles from European Journal of Surgical Oncology are provided here courtesy of Elsevier

RESOURCES